Rebecca Limer

London UK

Contact Me Today

Rebecca is a senior associate in the Patents and Innovation Group. She advises clients on contentious patent matters and the commercialisation of intellectual property.

Rebecca has litigated in the High Court, Court of Appeal, and at the UK IPO. She regularly works on multi-jurisdictional cases and has particular experience advising clients in the life sciences and telecoms sectors. Prior to qualifying as a solicitor Rebecca worked in the life sciences sector, negotiating clinical trials and R&D related contracts.

CV

Since 2024 Senior Associate, Taylor Wessing

2021 - 2024 Associate, Taylor Wessing

2017 - 2021 Associate, Gowling WLG

Career

Since 2024 Senior Associate, Taylor Wessing

2021 - 2024 Associate, Taylor Wessing

2017 - 2021 Associate, Gowling WLG

Education

2019 IP Transactions: Law and Practice, University College London

2018 Post Graduate Diploma, Intellectual Property Law and Practice, University of Oxford

2017 Admitted as a Solicitor, England & Wales

Memberships & Associations

IPSoc

Rebecca's news & insights

View Rebecca's insights

Click here to find out more

Patents & innovation

The development of the UK's SEP/FRAND landscape since Unwired Planet v Huawei – part one

30 January 2026

by multiple authors

Synapse - AI in Life Sciences

Revocation of life sciences patents in the UPC

The Unified Patent Court (UPC), active since June 2023, is seeing strong uptake in pharma and biotech. Revocation decisions show a balanced 50:50 win rate for patentees and challengers. Key legal standards on novelty, obviousness, and inventive step are emerging, though some aspects remain unclear. Strategic use of the UPC offers broad enforcement, but revocation risks are higher for single-patent portfolios. Legal uncertainties, like the Bolar exemption, still need clarification.

17 June 2025

by Lydia Birch and Rebecca Limer

4 of 5 Insights

Click here to find out more